-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) rose 3% on Friday . The stock traded as high as $6.77 and last traded at $6.61. Approximately 653,438 shares traded hands during trading, a decline of 81% from the average daily volume of 3,376,665 shares. The stock had previously closed at $6.42.
Mind Medicine (MindMed) Price Performance
The business has a 50-day simple moving average of $6.00 and a two-hundred day simple moving average of $7.63.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- 3 Fintech Stocks With Good 2021 Prospects
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Trading Halts Explained
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Consumer Staples Stocks, Explained
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
